Scheme

HDFC Pharma and Healthcare Fund

Holds 38 companies worth ₹3,388 Cr in Sept 2026.

Fund house
HDFCThe fund house that runs this scheme.
AUM
₹3,501 CrHDFC Pharma and Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Up 5.8% on Aug 2026, ₹3,311 Cr.
Largest holding
Divi s Laboratories LimitedDivi s Laboratories Limited is 9.4% of this scheme's NAV.
Fund manager
Nikhil MathurRuns it since 4 Oct 2023, as the fund house dates it. With Bhagyesh Kagalkar (gold & silver), Gopal Agrawal (overseas).

Holdings^{(Oct 2023 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	38 companies ·	₹ Cr
	Divi s Laboratories Limited	329
	Sun Pharmaceutical Ind Ltd	290
	Alkem Laboratories Limited	163
	Cipla	145
	Apollo Hospitals Enterprise Limited	129
	Torrent Pharmaceuticals Limited	128
	Max Healthcare Institute Limited	126
	Aster DM Healthcare Limited	125
	Lupin	124
	Neuland Laboratories Limited	114
	Shilpa Medicare Limited	113
	Dr Reddy s Laboratories Limited	112
	Acutaas Chemicals Limited	111
	Anthem Biosciences Limited	111
	IPCA Laboratories Limited	104
	Global Health Limited	95.3
	Rubicon Research Limited	88.2
	Krishna Institute of Medical Science Ltd	73.5
	Glenmark Pharmaceuticals	73.1
	Molbio Diagnostics Limited	70.4
	Vijaya Diagnostic Centre Limited	70.2
	Cadila Healthcare	63.8
	Gland Pharma Limited	62.3
	Wockhardt	60
	Jupiter Life Line Hospitals Limited	59
	Metropolis Healthcare Limited	58.6
	Sai Life Sciences Limited	55.2
	Biocon	51.5
	Symbiotec Pharmalab Limited	47.6
	Thyrocare Technologies Ltd	38.4
	Corona Remedies Limited	36.3
	Entero Healthcare Solutions Limited	35.4
	Jubilant Life Sciences	32.7
	Eris Lifesciences Limited	32.3
	Novartis India Ltd	19.3
	Bajaj Healthcare Limited	18.6
	Laxmi Dental Limited	12.3
	Cohance Lifesciences Limited	11.1

Divi s Laboratories Limited
Sun Pharmaceutical Ind Ltd

Market value of each ticked company in HDFC Pharma and Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Divi s Laboratories Limited	Sun Pharmaceutical Ind Ltd
Sept 2025	₹147 Cr	₹198 Cr
Oct 2025	₹175 Cr	₹210 Cr
Nov 2025	₹168 Cr	₹228 Cr
Dec 2025	₹166 Cr	₹214 Cr
Jan 2026	₹161 Cr	₹183 Cr
Feb 2026	₹170 Cr	₹199 Cr
Mar 2026	₹162 Cr	₹202 Cr
Apr 2026	₹185 Cr	₹174 Cr
May 2026	₹189 Cr	₹217 Cr
Jun 2026	₹187 Cr	₹260 Cr
Jul 2026	₹269 Cr	₹284 Cr
Aug 2026	₹316 Cr	₹296 Cr
Sept 2026	₹329 Cr	₹290 Cr

Fig. 1.Market value of each ticked company in HDFC Pharma and Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	5	29.16

Mid Cap	10	30.08

Small Cap	21	34.16

Unlisted	2	3.37

Cash & others		3.23

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	3.54L	329	9.39
Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	16L	290	8.28
Alkem Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	3.15L	163	4.64
Cipla	Equity	Pharmaceuticals & Biotechnology	10.8L	145	4.15
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	1.58L	129	3.69
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	2.66L	128	3.65
Max Healthcare Institute Limited	Equity	Healthcare Services	13.6L	126	3.61
Aster DM Healthcare Limited	Equity	Healthcare Services	17.9L	125	3.56
Lupin	Equity	Pharmaceuticals & Biotechnology	6.12L	124	3.55
Neuland Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	53.2K	114	3.24
Shilpa Medicare Limited	Equity	Pharmaceuticals & Biotechnology	10.8L	113	3.23
Dr Reddy s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	9.05L	112	3.19
Acutaas Chemicals Limited	Equity	Pharmaceuticals & Biotechnology	3.39L	111	3.18
Anthem Biosciences Limited	Equity	Pharmaceuticals & Biotechnology	12.9L	111	3.17
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	5.42L	104	2.98
Global Health Limited	Equity	Healthcare Services	6.98L	95.3	2.72
Rubicon Research Limited	Equity	Pharmaceuticals & Biotechnology	5.44L	88.2	2.52
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	9.85L	73.5	2.10
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	3.13L	73.1	2.09
Molbio Diagnostics Limited	Equity	Healthcare Equipment & Supplies	5.38L	70.4	2.01
Vijaya Diagnostic Centre Limited	Equity	Healthcare Services	4.88L	70.2	2.00
Cadila Healthcare	Equity	Pharmaceuticals & Biotechnology	5.49L	63.8	1.82
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	2.15L	62.3	1.78
Wockhardt	Equity	Pharmaceuticals & Biotechnology	2.83L	60	1.71
Jupiter Life Line Hospitals Limited	Equity	Healthcare Services	23.2L	59	1.68
Metropolis Healthcare Limited	Equity	Healthcare Services	10.8L	58.6	1.67
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	3.62L	55.2	1.58
Biocon	Equity	Pharmaceuticals & Biotechnology	13.9L	51.5	1.47
Symbiotec Pharmalab Limited	Equity	Pharmaceuticals & Biotechnology	4.05L	47.6	1.36
Thyrocare Technologies Ltd	Equity	Healthcare Services	7.19L	38.4	1.10
Corona Remedies Limited	Equity	Pharmaceuticals & Biotechnology	1.73L	36.3	1.04
Entero Healthcare Solutions Limited	Equity	Retailing	2.07L	35.4	1.01
Jubilant Life Sciences	Equity	Pharmaceuticals & Biotechnology	3.18L	32.7	0.93
Eris Lifesciences Limited	Equity	Pharmaceuticals & Biotechnology	2.71L	32.3	0.92
Novartis India Ltd	Equity	Pharmaceuticals & Biotechnology	1.01L	19.3	0.55
Bajaj Healthcare Limited	Equity	Pharmaceuticals & Biotechnology	5.69L	18.6	0.53
Laxmi Dental Limited	Equity	Healthcare Equipment & Supplies	6.44L	12.3	0.35
Cohance Lifesciences Limited	Equity	Pharmaceuticals & Biotechnology	2.5L	11.1	0.32

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.